Skip to main content
HR 2871 115th Congress House

Preserving Patient Access to Compounded Medications Act of 2017

Official title: To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding pharmacies, and for other purposes.

Introduced: June 15, 2017 Introduced by: Griffith, H. Morgan Republican · Virginia See on congress.gov
Health Administrative law and regulatory proceduresBusiness recordsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulation
More subjectsShow fewer subjects
Nutrition and dietPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 16, 2017
Referred to the Subcommittee on Health.
Jun 12, 2017
Referred to the House Committee on Energy and Commerce.
Jun 12, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 16, 2017

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Preserving Patient Access to Compounded Medications Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the circumstances under which a drug may be compounded (manufactured at small scale) to allow pharmacists and physicians to compound drugs for administration to patients in an office or clinical setting, in accordance with state law. (Drugs that are compounded do not need to meet certain federal requirements regarding manufacturing, labeling, or approval.)

Dietary supplements may be used in the compounding of a drug.

The bill exempts from interstate distribution limits the dispensing of a compounded drug from the facility where it is compounded to a patient or health facility.

The scope of Food and Drug Administration (FDA) inspections of compounding pharmacies is limited to pertinent equipment, materials, containers, and labeling, which is the same scope as inspections of pharmacies. (Currently, the scope of inspections of compounding pharmacies is the same scope as inspections of drug manufacturers.)

The bill eliminates the requirement for compounding pharmacies to register with the FDA as drug manufacturers.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 43
All 43 Democratic 3 Republican 19
Bishop, Rob
· Jul 26, 2018
SHIMKUS, JOHN
· Jul 23, 2018
 R
Loudermilk, Barry
Georgia · Jul 16, 2018
 D
Norcross, Donald
New Jersey · Jul 13, 2018
Amash, Justin
· Jul 12, 2018
Jenkins, Evan
· Jun 27, 2018
 R
Johnson, Mike
Louisiana · Jun 6, 2018
 R
Higgins, Clay
Louisiana · Jun 1, 2018
Herrera Beutler, Jaime
· May 25, 2018
 R
Amodei, Mark E.
Nevada · May 21, 2018
 R
Budd, Ted
North Carolina · May 7, 2018
 R
Palmer, Gary J.
Alabama · Apr 27, 2018
DUNCAN, JOHN
· Apr 12, 2018
MacArthur, Thomas
· Feb 26, 2018
Duffy, Sean
· Jan 18, 2018
Taylor, Scott
· Jan 9, 2018
 R
Calvert, Ken
California · Dec 22, 2017
Blum, Rod
· Oct 10, 2017
Lewis, Jason
· Oct 10, 2017
 R
Marshall, Roger
Kansas · Oct 10, 2017
GOODLATTE, ROBERT
· Sep 27, 2017
McSally, Martha
· Sep 26, 2017
 R
Cramer, Kevin
North Dakota · Sep 25, 2017
 R
DesJarlais, Scott
Tennessee · Sep 12, 2017
 R
Wittman, Robert J.
Virginia · Sep 12, 2017
 R
Barr, Andy
Kentucky · Sep 5, 2017
Collins, Doug
· Sep 5, 2017
Comstock, Barbara
· Sep 5, 2017
 R
LaHood, Darin
Illinois · Sep 5, 2017
 R
Babin, Brian
Texas · Jul 24, 2017
 D
Beatty, Joyce
Ohio · Jul 24, 2017
Brat, Dave
· Jul 20, 2017
 R
Dunn, Neal P.
Florida · Jul 20, 2017
 R
Gosar, Paul A.
Arizona · Jul 18, 2017
Young, David
· Jul 13, 2017
Harper, Gregg
· Jul 12, 2017
 R
Biggs, Andy
Arizona · Jun 27, 2017
THORNBERRY, WILLIAM
· Jun 22, 2017
 R
Carter, Earl L. "Buddy"
Georgia · Jun 21, 2017
LOBIONDO, FRANK
· Jun 21, 2017
 R
Sessions, Pete
Texas · Jun 21, 2017
Collins, Chris
· Jun 15, 2017
 D
Cuellar, Henry
Texas · Jun 12, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2871: Preserving Patient Access to Compounded Medications Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2871/
MLA
"H.R. 2871: Preserving Patient Access to Compounded Medications Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2871/.
Bluebook (legal)
H.R. 2871, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2871/.
Markdown link
[H.R. 2871: Preserving Patient Access to Compounded Medications Act of 2017](https://openamerica.io/bill/115-HR-2871/)
Report a problem